Markus Glaffig
Mainz, RP 55128, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Synthetic MUC1 Antitumor Vaccine with Incorporated 2,3-Sialyl-T Carbohydrate Antigen Inducing Strong Immune Responses with Isotype Specificity.
Journal: Chembiochem : a European journal of chemical biology
Published: March 17, 2018
Immunization with a Synthetic Human MUC1 Glycopeptide Vaccine against Tumor-Associated MUC1 Breaks Tolerance in Human MUC1 Transgenic Mice.
Journal: ChemMedChem
Published: July 03, 2017
Enhanced immunogenicity of multivalent MUC1 glycopeptide antitumour vaccines based on hyperbranched polymers.
Journal: Organic & biomolecular chemistry
Published: August 25, 2015
CpG-loaded multifunctional cationic nanohydrogel particles as self-adjuvanting glycopeptide antitumor vaccines.
Journal: Advanced healthcare materials
Published: July 30, 2014
A fully synthetic four-component antitumor vaccine consisting of a mucin glycopeptide antigen combined with three different T-helper-cell epitopes.
Journal: Angewandte Chemie (International ed. in English)
Published: July 03, 2014
A fully synthetic glycopeptide antitumor vaccine based on multiple antigen presentation on a hyperbranched polymer.
Journal: Chemistry (Weinheim an der Bergstrasse, Germany)
Published: January 22, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026